Strongbridge Biopharma plc
SBBPDelisted Oct 5, 2021- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634432
Strongbridge Biopharma plc was delisted on Oct 5, 2021; its insiders filed their last Form 4 on Jan 5, 2022; 49 institutions reported holding it in 13F filings for Q3 2021, worth $69.8M in total; Fairfax Financial was the only superinvestor holding it.
Superinvestors holding SBBP, Q3 2021
1 superinvestor reports holding Strongbridge Biopharma plc on Form 13F, worth $392.0K in total. Weight is Strongbridge Biopharma plc's share of each 13F portfolio; actions compare shares with Q2 2021.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Fairfax FinancialPrem Watsa | <0.1% | 193,107 | $392.0K | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SBBP each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
1 superinvestor holding at quarter end